ATMP Service Providers Market Expansion Driven by Increasing Adoption of Gene Therapy, Cell Therapy, and Tissue Engineered Products

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global ATMP Service Providers Market by Type of Services (Analytics/CRO (Microbiology, Endotoxin, PCR, Flow Cytometry, ELISA, Container Closure, Sterilty, and Pre-clinical), Quality (Documentation, QMS And Regulations), CMO (HQ/GMP plasmid DNA, MSC Manufacture, Pluripotent Stem Cells), Logistics (Storage, Stability And Transport)), Application (GTMP(Gene Therapy Medicinal Products), sCTMP(somatic Cells Therapy Medicinal Products) and TEP(Tissue Engineered Products))-Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the Global ATMP Service Providers Market is valued at 16.68 Billion in 2024, and it is expected to reach 42.57 Billion by the year 2034, with a CAGR of 9.9% during the forecast period of 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1228

Advanced Therapy Medicinal Products (ATMPs) represent innovative treatments developed using specifically engineered cells, genes, and tissues. These therapies enable personalized and targeted medical interventions that address diseases at their root cause, offering transformative potential beyond conventional, one-size-fits-all pharmaceuticals. ATMPs present groundbreaking opportunities for treating life-threatening conditions, often achieving curative effects with one or limited doses. Critical to the development of ATMPs is the characterization and analysis that provide essential chemistry, manufacturing, and control (CMC) data required for Investigational New Drug (IND) applications, as well as for stability testing and product release. Service providers play a vital role throughout product development, supporting early-stage research, in-process control, and final product release assays.

The increasing global prevalence of chronic conditions such as diabetes, cancer, cardiovascular diseases, and genetic disorders like cystic fibrosis is driving demand for personalized medicine and advancements in biological therapies, fueling growth in the ATMP service provider market. The majority of novel advanced therapy products are currently being developed in the United States and European Union. Additionally, companies are seeking cost-effective clinical trial opportunities in emerging markets, which present promising prospects for ATMP service providers. Significant investments by both commercial and non-commercial sponsors in clinical testing of cell-based product candidates are expected to further accelerate market growth.

Nevertheless, high treatment costs and limited health insurance coverage pose challenges to market expansion. Furthermore, constraints related to manufacturing capacity and budgetary limitations faced by ATMP developers have created opportunities for contract service providers, intensifying market competition.

Regionally, North America holds the largest revenue share, driven by substantial investment and a rapid increase in clinical trials involving advanced therapies. The Asia Pacific region is also anticipated to experience considerable growth, supported by strategic collaborations and a robust pipeline of ATMP candidates that are accelerating revenue generation in the market.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Significant market players are Takara Bio, NorthX Biologics, Cellco Labs, AWA, ClinStorage, Key2Complience, Nordic BioAnalysis, YSDS, Truly Labs, ABC Labs, Mikrolabs, NDA group, Propharma group, Celonic, Bio Elpida, CGT Catapult, Rentschler Biopharma SE, AGC Biologics, WuXi Advanced Therapies, BlueReg, Minaris Regenerative Medicine, Patheon, Bio-Techne Corporation, bioMérieux SA, Catalent, Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Intertek Group plc, Lonza Group AG, Merck KGaA, Sartorius AG, SGS S.A., Sistemic Scotland Limited, Thermo Fisher Scientific Inc., Vigene Biosciences, Inc., WuXi AppTec and others.

Key Developments in the market
• In Mar 2022, Rentschler Biopharma and Vetter Unveil Xpert Alliance. This strategic collaboration delivers effective solutions to address clients' changing and expanding needs in the area of complex biopharmaceuticals.
• In Oct 2021, The Swedish government, through their Life Sciences department, announced a 36 million SEK investment to the Swedish Innovation agency (Vinnova) to establish an Innovation hub enabling the production of Advanced Therapy Medicinal Products (ATMPs) and DNA and RNA based vaccines.
• In Sept 2021, Lonza announced plans to expand drug manufacturing capabilities at its Stein facility in Switzerland. Lonza's investment aims to expand its overall drug product development and manufacturing services.
• In June 2021, Bio-Techne Corporation and Catamaran Bio announced an expansion of their collaboration to develop cell engineering and cell process technologies for use by Catamaran in the manufacturing of CAR-NK cell therapy products.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1228

Market Segments
Global ATMP Service Providers Market, by Type of Service, 2022-2030 (Value US$ Mn)
• Analytics/CRO
o Microbioilogy
o Endotoxin
o PCR
o Flow Cytometry
o ELISA
o Container Closure
o Sterility
o Pre-clinical
• Quality
o Documentation
o QMS
o Regulations
• CMO
o HQ/GMP Plasmid DNA
o MSC Manufacture
o Pluripotent Stem Cells
• Logistics
o Storage
o Stability
o Transport
Global ATMP Service Providers Market, by Application, 2022-2030 (Value US$ Mn)
• GTMP
• sCTMP
• TEP
Global ATMP Service Providers Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
• To receive a comprehensive analysis of the prospects for the Global ATMP Service Providers Market
• To receive an industry overview and future trends of the ATMP Service Providers Market
• To analyze the ATMP Service Providers Market drivers and challenges
• To get information on the ATMP Service Providers Market Size (Value US$ Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the ATMP Service Providers Market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-atmp-service-providers-market-/1228

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.